(Tehran Ana)- DNA testing can reveal genetic risks for diseases such as Alzheimer’s, diabetes and certain cancers years before symptoms appear. But how accurately can our genes predict our health ...

Alpha-1 antitrypsin deficiency (AATM) is a congenital metabolic disorder. It is caused by a genetic defect, which results in ...

By Deena Beasley Nov 2 (Reuters) - The recent failure of a Novartis experimental heart drug in a large trial raised questions ...

A new biotech born from Jazz Pharmaceuticals' acquisition deal is betting that rare disease genetics can unlock treatments ...

Opus Genetics is a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs). The Company is ...

Researchers at Endeavor Health and GoPath Diagnostics have developed a new genetic test that can help predict which men with prostate cancer are most likely to develop aggressive, life-threatening ...

In a landmark achievement in the field of genetic medicine, researchers have reported the very first published case in a peer-reviewed journal of a successful clinical treatment of a patient with ...

Dublin, Nov. 02, 2026 (GLOBE NEWSWIRE) -- "Rare Disease Contract Research Organization (CRO) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces that Myriad management will participate in three upcoming healthcare conferences.

Alamar Biosciences, Inc. (Nasdaq: ALMR) and Nightingale Health Plc (Nasdaq Helsinki: HEALTH, OTCQX: NHLTY, NGHLF) today announced the launch of the UK Biobank vanguard study to measure blood-based ...

The University of Maine is expanding its tick lab as ticks become more widespread across the state.

Colin turned his life around for the better when his eldest son James, 23, was diagnosed with a rare neurological disease called Angelman syndrome aged two.